New NHS access for SMA treatments shows why specialist medicines need strong GDP systems, supplier checks and route planning.
Tell us where you are in the regulated route and we will help you understand the safest next step.
Your information will only be used by us in line with our Privacy Notice.
Tell us where you are in the regulated route and we will help you understand the safest next step.
Your information will only be used by us in line with our Privacy Notice.
New NHS access for SMA treatments shows why specialist medicines need strong GDP systems, supplier checks and route planning.
A new MHRA Braille labelling notice shows why wholesalers need strong product information controls, GDP systems and RP oversight.
A new MHRA medicine approval shows why wholesalers need GDP readiness, product information controls and customer route planning.
© 2026 Stag Global Ltd is part of the TPMG Group and is supported by TPMG Group Services Ltd, operating as Shared Services Hub, for selected governance, administration, document control and compliance support functions. Certain policies are maintained centrally through Shared Services Hub and adopted by relevant TPMG Group businesses. Where a policy applies to a specific company, the applicable legal entity is identified within the policy, schedule or related notice.